NCT06741774Active, not recruiting
Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO )
Efficacy and Safety of Trabecular Meshwork Microstent Drainage System in Reducing Intraocular Pressure in Adult Patients with Mild to Moderate Open-angle Glaucoma Combined with Cataract: a Prospective, Multicenter, Randomized, Open Label, Parallel Controlled, Superiority Clinical Trial
Source: ClinicalTrials.gov · Last updated 19 Dec 2024
Brief summary (registry, in English)
It is a prospective, multicenter, randomized, open label, parallel controlled, superiority clinical trial that evaluate efficacy and safety of Trabecular Meshwork Microstent Drainage System in Reducing Intraocular Pressure in Adult Patients With Mild to Moderate Open-angle Glaucoma Combined With Cataract.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 207 (estimated)
- First submitted
- 9 Dec 2024
- Start date
- 19 Oct 2022
- Primary completion date
- 4 Dec 2025
- Lead sponsor
- Healthguard Biomed
- Diseases
- Glaucoma
- NCT number
- NCT06741774
What you commit to
- Study type: Interventional
- Planned participants: 207
- From 19 Oct 2022 to the primary completion date, 4 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Traumatic, uveitic, neovascular, angle-closure glaucoma or glaucoma associated with vascular disorders
- Retinal disorders not associated with glaucoma
Other
- Active corneal inflammation or edema
Who the study is looking for
- Male of female, age 18 years or older
- Mild to moderate open-angle glaucoma
- Cataract
- Average of IOP is less than or equal to 24mmHg with 1-3 drugs in the screening period
- All 3 diurnal IOPs after drug-eluting are greater than 21mmHg and less than or equal to 35mmHg, average of diurnal IOPs is at least 3.0mmHg higher than the pre drug-eluting IOP
- Cup to disc ratio (C/D) less than or equal to 0.8, or VFI greater than 75%
- Gonioscope shows that anterior chamber angle is open
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Healthguard Biomed Coordinator of this site? Confirm its status | Suzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.